Skip to main content

Oncolytics Bio(ONC-T)
TSX

Today's Change
Real-Time Last Update
Day Low1.50
Day High1.57
Open:1.57
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Baystreet
Stocks in play: Oncolytics Biotech Inc
Baystreet
Stocks in play: Oncolytics Biotech Inc
Baystreet
Stocks in play: Oncolytics Biotech Inc
Newsfile
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning
Baystreet
Stocks in play: Oncolytics Biotech Inc
GlobeNewswire
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
Baystreet
Stocks in play: Oncolytics Biotech Inc
Baystreet
Stocks in play: Oncolytics Biotech Inc.
Baystreet
Stocks in play: Oncolytics Biotech Inc
Newsfile
Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments
Baystreet
Stocks in play: Oncolytics Biotech Inc
GlobeNewswire
Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies
Baystreet
Stocks in play: Oncolytics Biotech Inc.
GlobeNewswire
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
Baystreet
Stocks in play: Oncolytics Biotech Inc
Baystreet
Stocks in play: Oncolytics Biotech Inc.

Profile

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.